Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Positive crawled date : 2022 - 06 - 10 save search
GSK’s RSV vaccine candidate for older adults, containing Agenus’ QS-21 STIMULON™ as part of GSK’s AS01 adjuvant, reports positive pivotal data supporting initiation of global regulatory submissions
Published: 2022-06-10 (Crawled : 13:00) - biospace.com/
AGEN | $5.3 6.64% 6.23% 1.5M
|
Health Technology
|
| O: -6.51%
H: 0.0%
C: 0.0%
qs-21 vaccine positive order
Cogent Biosciences Announces Positive Initial Clinical Data from Ongoing Phase 2 APEX Trial Evaluating Bezuclastinib in Patients with Advanced Systemic Mastocytosis (AdvSM)
Published: 2022-06-10 (Crawled : 12:20) - biospace.com/
COGT | $6.71 1.51% 1.49% 1.5M
|
Health Technology
|
| O: 40.81%
H: 0.0%
C: 0.0%
ongoing trial positive phase 2
Amarin Receives Positive Recommendation from United Kingdom’s (UK) National Institute for Health and Care Excellence (NICE) for Reimbursement of VAZKEPA® (icosapent ethyl)
Published: 2022-06-10 (Crawled : 12:00) - biospace.com/
AMRN | $0.88 0.94% 0.93% 1M
|
Health Technology
|
| O: -2.17%
H: 0.0%
C: 0.0%
vazkepa care health positive
Cyclerion Therapeutics Announces Positive Topline Clinical Data for CY6463 in MELAS Patients at UMDF Mitochondrial Medicine 2022 Symposium
Published: 2022-06-10 (Crawled : 11:00) - ir.cyclerion.com
CYCN | $3.315 12.62% 3.3K
|
Health Technology
|
| O: -20.73%
H: 0.0%
C: 0.0%
cy6463 topline symposium therapeutics positive
Caribou Biosciences Reports Positive Additional Data from CB-010 Allogeneic CAR-T Cell Therapy Phase 1 ANTLER Trial at the European Hematology Association (EHA) 2022 Hybrid Congress
Published: 2022-06-10 (Crawled : 08:00) - globenewswire.com
CRBU | $3.87 -1.02% -1.03% 1.7M
|
Health Technology
|
| O: -22.27%
H: 0.0%
C: 0.0%
cb-010 car-t trial positive therapy phase 1
GBT Presents Positive New Real-World Evidence Data at EHA2022 Congress Further Supporting Clinical Use of Oxbryta® (voxelotor) in Sickle Cell Disease
Published: 2022-06-10 (Crawled : 08:00) - globenewswire.com
GBT | $68.49 0.02% -0.02%
|
Health Technology
|
| O: -6.01%
H: 0.0%
C: 0.0%
eha2022 oxbryta disease positive
Imago BioSciences Presents Positive Data from Ongoing Phase 2 Study of Bomedemstat in Essential Thrombocythemia at EHA 2022
Published: 2022-06-10 (Crawled : 08:00) - globenewswire.com
IMGO | $36.01 0.03% 0.0% 0
|
Health Technology
|
| O: -7.77%
H: 0.0%
C: 0.0%
ongoing positive phase 2
Imago BioSciences Presents Positive Data from Ongoing Phase 2 Study of Bomedemstat in Advanced Myelofibrosis at EHA 2022
Published: 2022-06-10 (Crawled : 08:00) - globenewswire.com
IMGO | $36.01 0.03% 0.0% 0
|
Health Technology
|
| O: -7.77%
H: 0.0%
C: 0.0%
ongoing positive phase 2
Genentech Announces Positive Data from Broad Blood Cancer Portfolio at European Hematology Association Annual Meeting
Published: 2022-06-10 (Crawled : 08:00) - biospace.com/
FNCTF | News | $11.0354 -20.84% 320
|
Communications
| Email alert
Add to watchlist
blood positive cancer
Gainers vs Losers
| 69% | 31% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
KNW 4 | $0.59 -0.71% 18.64% 27K
|
Manufacturing
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | News | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.